- AbiVax falls as safety worries cloud ‘landmark’ immune drug results<figure><div><img src="https://imgproxy.divecdn.com/xa_T0oT9Hj8F-wJjKfJeFkbn4Yqp_lT58dL0S4GszxY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjEzNjQ4MDJfMS5qc…BioPharma Dive · 1mo ago↗ source
- ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer<p>At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.</p>BioPharma Dive · 1mo ago↗ source
- Why US-manufactured pharmaceutical packaging equipment matters<p>As manufacturers modernize operations, the origin of their equipment is a strategic consideration.</p>